Artificial Intelligence in Signal Detection


An information that suggests a potential causal association between an intervention and an event, indicating the possibility of unintended outcomes. A signal might uncover rare but dangerous side effect in a marketed drug did not emerge in clinical trials. Generally, signal detection was a reactive process. If an adverse event, such as a heart attack, was reported by a patient or their physician, related to a specific treatment, the report would be studied and actions taken if the signal proved reliable and meaningful to the context of the treatment.      



 


  • Proactive signal detection
  • Passive Wi-Fi sensing system
  • Artificial Intelligence Detection

Related Conference of Artificial Intelligence in Signal Detection

November 27-28, 2025

4th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 27-28, 2025

4th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
December 01-02, 2025

13th International Conference on Clinical Trials

Vancouver, Canada
January 29-30, 2026

19th World Drug Delivery Summit

Paris, France
February 10-11, 2026

40th World Congress on Pharmacology and Therapeutics

Barcelona, Spain
February 23-24, 2026

3rd World Congress on Biologics and Biosimilars

London, UK
March 23-24, 2026

36th Annual European Pharma Congress

London, UK
March 24-25, 2026

11th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
April 16-17, 2026

19th European Biosimilars Congress

Rome, Italy
April 27-28, 2026

9th European Biopharma Congress

Paris, Aland Islands
May 28-29, 2026

3rd International Conference on Pharmacognosy

Madrid, Spain
July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy

Artificial Intelligence in Signal Detection Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in